RPS6KB2 and cancer: Unexpectedly, silencing of p70S6K2, a key regulator of the PI3K pathway, remarkably reduced the activity of GLI regulatory gene, indicating that p70S6K2 may serve as a therapeutic target to inactivate the HH cascade in cancer.